President Trump Launches TrumpRx, Promising Lower Drug Prices: Is It Legit?

In brief

• TrumpRx.gov aggregates steep cash-pay discounts on more than 40 branded drugs, routing users to manufacturers or pharmacies without insurance or accounts.
• GLP-1 drugs like Ozempic, Wegovy, and Zepbound anchor the launch, with prices cut by as much as 85–93% from U.S. list prices under a most-favored-nation framework.
• Supporters hail the platform as a breakthrough on affordability, while critics argue it benefits a narrow slice of patients and sidesteps deeper reforms to insurance and drug…